Schwartz Investment Counsel Inc Haemonetics Corp Transaction History

Schwartz Investment Counsel Inc

$2.52 Billion
Q2 2024

A detailed history of Schwartz Investment Counsel Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Schwartz Investment Counsel Inc holds 151,000 shares of HAE stock, worth $12.1 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

151,000

Previous 151,000 -0.0%

Holding current value

$12.1 Million

Previous $12.9 Million 3.07%

% of portfolio

0.5%

Previous 0.5%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$71.24 - $85.35 $2.28 Million - $2.73 Million	32,000 Added 26.89%	151,000 $12.9 Million
Q3 2023 Oct 17, 2023	SELL	$82.56 - $93.49 $3.3 Million - $3.74 Million	-40,000 Reduced 25.16%	119,000 $10.7 Million
Q1 2023 May 08, 2023	SELL	$72.75 - $90.6 $1.82 Million - $2.27 Million	-25,000 Reduced 13.59%	159,000 $13.2 Million
Q3 2022 Nov 10, 2022	SELL	$63.3 - $78.66 $316,500 - $393,300	-5,000 Reduced 2.65%	184,000 $13.6 Million
Q1 2022 May 12, 2022	BUY	$43.77 - $63.22 $2.23 Million - $3.22 Million	51,000 Added 36.96%	189,000 $11.9 Million
Q4 2021 Feb 08, 2022	BUY	$49.55 - $74.59 $1.39 Million - $2.09 Million	28,000 Added 25.45%	138,000 $7.32 Million
Q3 2021 Nov 10, 2021	BUY	$57.6 - $70.59 $1.15 Million - $1.41 Million	20,000 Added 22.22%	110,000 $7.77 Million
Q2 2021 Aug 12, 2021	BUY	$51.81 - $118.56 $1.55 Million - $3.56 Million	30,000 Added 50.0%	90,000 $6 Million
Q4 2020 Feb 12, 2021	BUY	$88.75 - $119.95 $887,500 - $1.2 Million	10,000 Added 20.0%	60,000 $7.13 Million
Q3 2020 Nov 17, 2020	BUY	$75.65 - $93.58 $1.89 Million - $2.34 Million	25,000 Added 100.0%	50,000 $4.36 Million
Q2 2020 Aug 10, 2020	BUY	$84.96 - $118.91 $2.12 Million - $2.97 Million	25,000 New	25,000 $2.24 Million

Others Institutions Holding HAE

# of Institutions

337

Shares Held

55.2M

Call Options Held

383K

Put Options Held

45.1K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.12B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schwartz Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schwartz Investment Counsel Inc with notifications on news.

Account

Schwartz Investment Counsel Inc Haemonetics Corp Transaction History